BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 12, 2025
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Oct. 28, 2025

Oct. 28, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Enable Injections, Grand Life, GSK, Hyloris, Incyte, Kadimastem, NLS, Organon, Syndivia, Targetgene.
Read More

Other news to note for Oct. 28, 2025

Oct. 28, 2025
Additional early-stage research and drug discovery news in brief, from: Actinium, Bridgebio Oncology, Monte Rosa, Cullinan Therapeutics.
Read More

Other news to note for Oct. 27, 2025

Oct. 27, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditxt, Alcon, Venus Medtech, Co-Diagnostics, Laplace Interventional, Orchestra, QT Imaging, Remedy Robotics, Staar.
Read More

Other news to note for Oct. 27, 2025

Oct. 27, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Biossil, Chugai, Elevara, Maruho, Medivir, Mitocarex, Nanobiotix, Nielsen, Renalys, Scisparc, Secarna, Scenic, Teijin.
Read More

Other news to note for Oct. 24, 2025

Oct. 24, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arthrolense, Baird Medical, Biolab, Pulse Biosciences, Smart Reporting, Terraplasma Medical, Waldemar Link.
Read More

Other news to note for Oct. 24, 2025

Oct. 24, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Adverum, Biogen, Cassava, Eli Lilly, Sanofi, Vanqua.
Read More

Other news to note for Oct. 23, 2025

Oct. 23, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Angiopro, Cormedix, Emboline, Euda Health, Inspira Technologies, Nauticus, Neurent Medical, Omed Health, Owlstone Medical, Profusa.
Read More

Other news to note for Oct. 23, 2025

Oct. 23, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: AAX, Biossil, Daiichi Sankyo, Forlong, Galera, Henlius, Kyowa Kirin.
Read More

Other news to note for Oct. 23, 2025

Oct. 23, 2025
Additional early-stage research and drug discovery news in brief, from: Lakewood-Amedex, Simcha Therapeutics.
Read More

Other news to note for Oct. 22, 2025

Oct. 22, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ainnova, Becton Dickinson, Femasys, Histosonics, Innerscope, Nyra, Ventric.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 1381 1382 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 12, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 11, 2025.
  • Red dollar sign under microscope

    Medline plans record-setting $5.37B IPO

    BioWorld MedTech
    Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Flow FL 100 on patient

    Flow Neuro wins FDA nod for at-home device for depression

    BioWorld MedTech
    Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major depressive disorder. The wearable headset uses...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing